Inspire Medical Systems Income After Taxes 2017-2024 | INSP

Inspire Medical Systems income after taxes from 2017 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
Inspire Medical Systems Annual Income After Taxes
(Millions of US $)
2024 $54
2023 $-21
2022 $-45
2021 $-42
2020 $-57
2019 $-33
2018 $-22
2017 $-18
2016 $-19
Inspire Medical Systems Quarterly Income After Taxes
(Millions of US $)
2024-12-31 $35
2024-09-30 $18
2024-06-30 $10
2024-03-31 $-10
2023-12-31 $15
2023-09-30 $-9
2023-06-30 $-12
2023-03-31 $-15
2022-12-31 $3
2022-09-30 $-17
2022-06-30 $-14
2022-03-31 $-17
2021-12-31 $-2
2021-09-30 $-10
2021-06-30 $-13
2021-03-31 $-16
2020-12-31 $-7
2020-09-30 $-10
2020-06-30 $-23
2020-03-31 $-16
2019-12-31 $-9
2019-09-30 $-8
2019-06-30 $-8
2019-03-31 $-8
2018-12-31 $-5
2018-09-30 $-5
2018-06-30 $-6
2018-03-31 $-7
2017-12-31 $-4
2017-09-30 $-4
2017-06-30 $-5
2017-03-31 $-4
2016-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $4.470B $0.803B
Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $35.134B 48.53
Tempus AI (TEM) United States $6.966B 0.00
Hims & Hers Health (HIMS) United States $6.050B 97.25
IRhythm Technologies (IRTC) United States $3.223B 0.00
Privia Health (PRVA) United States $2.873B 215.27
Schrodinger (SDGR) United States $1.881B 0.00
Clover Health Investments (CLOV) United States $1.839B 0.00
Enovis (ENOV) United States $1.825B 11.29
Omnicell (OMCL) United States $1.418B 30.59
Phreesia (PHR) United States $1.409B 0.00
Azenta (AZTA) United States $1.154B 53.72
10x Genomics (TXG) United States $0.918B 0.00
Butterfly Network (BFLY) United States $0.568B 0.00
Fulgent Genetics (FLGT) United States $0.551B 0.00
Talkspace (TALK) United States $0.450B 267.00
Veradigm (MDRX) United States $0.449B 0.00
Standard BioTools (LAB) United States $0.440B 0.00
TruBridge (TBRG) United States $0.363B 0.00
Claritev (CTEV) United States $0.325B 0.00
Health Catalyst (HCAT) United States $0.270B 0.00
Nyxoah SA (NYXH) Belgium $0.206B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.189B 0.00
Pulmonx (LUNG) United States $0.182B 0.00
American Well (AMWL) United States $0.109B 0.00
EUDA Health Holdings (EUDA) Singapore $0.100B 0.00
Retrieve Medical Holdings (RMHI) United States $0.082B 0.00
MDxHealth SA (MDXH) Belgium $0.076B 0.00
P3 Health Partners (PIII) United States $0.066B 0.00
111 (YI) China $0.064B 0.00
CareCloud (CCLD) United States $0.060B 2.58
HeartBeam (BEAT) United States $0.055B 0.00
Outset Medical (OM) United States $0.040B 0.00
Zepp Health (ZEPP) China $0.039B 0.00
Zhongchao (ZCMD) China $0.030B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
MSP Recovery (MSPR) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Streamline Health Solutions (STRM) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Precipio (PRPO) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Syra Health (SYRA) United States $0.001B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00